A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease

BACKGROUND: Alzheimer's disease (AD) co‐pathology is common in dementia with Lewy bodies and is associated with increased decline. Plasma pTau181 is a blood‐based biomarker that can detect AD co‐pathology. OBJECTIVES: We investigated whether pTau181 was associated with cognitive decline in mild...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Alan J., Hamilton, Calum A., Heslegrave, Amanda, Barker, Sally, Durcan, Rory, Lawley, Sarah, Barnett, Nicola, Lett, Debbie, Firbank, Michael, Roberts, Gemma, Taylor, John‐Paul, Donaghy, Paul C., Zetterberg, Henrik, O'Brien, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540809/
https://www.ncbi.nlm.nih.gov/pubmed/35318733
http://dx.doi.org/10.1002/mds.28994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540809/
https://www.ncbi.nlm.nih.gov/pubmed/35318733
http://dx.doi.org/10.1002/mds.28994

Ejemplares similares